cepia

Clinical Epidemiology and Ageing

Early-phase myocardial uptake intensity of Tc-HMDP vs Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis.

Abulizi M, Cottereau A-S, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, Planté-Bordeneuve V, Dubois-Randé J-L, Bodez D, Rosso J, Damy T, Itti E J Nucl Cardiol. 2018;25(1):217-222.

BACKGROUND: This study sought to compare the intensity of early-phase myocardial uptake of two phosphonate-based radiotracers, Tc-hydroxymethylene diphosphonate (HMDP) and Tc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD), in patients with hereditary transthyretin-related cardiac amyloidosis (TTR-CA).

METHODS: Six patients with biopsy-proven diagnosis of TTR-CA and characteristic amyloid fibril composition underwent early-phase Tc-HMDP myocardial scintigraphy as part of their routine workup; they were later assessed by Tc-DPD scintigraphy after having signed informed written consent. Heart-to-mediastinum-ratio was measured at both time points as well as regional distribution on 17-segment analysis.

RESULTS: All patients had an H/M ratio >1.28 on both imaging. Tc-DPD uptake was slightly higher than Tc-HMDP uptake in 3 patients, but no statistical difference was found (P = 0.13). Regional distribution of the two radiotracers was well correlated on bull's eyes analysis, with only slight underestimation of Tc-DPD uptake in the anterior/apical segments, compared with Tc-HMDP.

CONCLUSION: Tc-HMDP and Tc-DPD show comparable myocardial uptake intensity on early-phase scintigraphy and can be used alternatively for the diagnosis of TTR-CA.

MeSH terms: Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Biopsy; Diphosphonates; Europe; Female; Heart; Humans; Male; Myocardium; Organotechnetium Compounds; Radionuclide Imaging; Regression Analysis; Technetium Tc 99m Medronate
DOI: 10.1007/s12350-016-0707-9